Cucurbitacine B derivative as well as preparation method and application thereof

The invention discloses a cucurbitacine B derivative and a preparation method and application thereof, the structure of the cucurbitacine B derivative is as shown in formula I. In the formula, the definition of each substituent group is as described in the specification and claims. The compound disclosed by the invention is simple and convenient to synthesize, has better anti-tumor and anti-inflammatory activity, and can be used for preparing anti-tumor and anti-inflammatory drugs. # imgabs0 #.

Medienart:

Patent

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Europäisches Patentamt - (2023) vom: 19. Sept. Zur Gesamtaufnahme - year:2023

Sprache:

Englisch

Beteiligte Personen:

NAN FAJUN [VerfasserIn]
LI JINGYA [VerfasserIn]
ZHUO NING [VerfasserIn]
CAO LEI [VerfasserIn]
SUN XINYU [VerfasserIn]
MA JIE [VerfasserIn]
KONG XIANGRONG [VerfasserIn]

Links:

Volltext [kostenfrei]

Themen:

Sonstige Themen:
615
A61K: Preparations for medical, dental, or toilet purpose (...)
A61P: Specific therapeutic activity of chemical compounds (...)
C07J: Steroids (seco-steroids c07c) (...)
che

Anmerkungen:

Source: www.epo.org (no modifications made), First posted: 2023-09-19, Last update posted on www.tib.eu: 2023-12-19, Last updated: 2023-12-22

Patentnummer:

CN116768955

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

EPA01823870X